2024-11-19 07:40:24
Ocumension Therapeutics Strengthens Pipeline for Posterior Segment Eye Diseases
Corporate/ 2023-07-23
Ocumension Therapeutics Strengthens Pipe...

HONG KONG,Oct. 30,2020-- October 30,2020,Ocumension Therapeutics(1477.HK) announcedthat the Company has entered into a collaboration and exc...

APRINOIA Announces Approval from NMPA to Initiate Phase 3 Clinical Trial in China for [18F]-APN-1607 Tau PET Imaging Tracer for Dementia
Health/ 2023-07-22
APRINOIA Announces Approval from NMPA to...

SUZHOU,China,Oct. 28,2020-- APRINOIA Therapeuticsannounced today that China National Medical Products Administration (NMPA) had approved to ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release